Center for Scientific Review; Notice of Closed Meetings, 47595 [2011-19878]

Download as PDF Federal Register / Vol. 76, No. 151 / Friday, August 5, 2011 / Notices Request for Comments: Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (2) the accuracy of the agency’s estimate of the burden of the proposed collection of information; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@omb.eop.gov or by fax to 202–395–6974, Attention: Desk Officer for NIH. To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact: Dr. Cathrine Sasek, Coordinator, Science Education Program, Office of Science Policy and Communications, National Institute on Drug Abuse, 6001 Executive Blvd, Room 5237, Bethesda, MD 20892, or call non-toll-free number (301) 443– 6071; fax (301) 443–6277; or by e-mail to csasek@nida.nih.gov. Comments Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. Dated: August 1, 2011. Mary Affeldt, Executive Officer, (OM Director, NIDA). [FR Doc. 2011–19877 Filed 8–4–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health erowe on DSKG8SOYB1PROD with NOTICES Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., VerDate Mar<15>2010 15:16 Aug 04, 2011 Jkt 223001 as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Chronic Illness and Anxiety. Date: August 23, 2011. Time: 2 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Monica Basco, PhD, Scientific Review Officer, RPHB IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3220, MSC 7808, Bethesda, MD 20892, 301–496– 7010, bascoma@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Biology and Diseases of the Posterior Eye. Date: September 13, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance, Washington, DC Hotel, 999 Ninth Street, NW., Washington, DC 20001–4427. Contact Person: Noni Byrnes, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5130, MSC 7840, Bethesda, MD 20892, (301)-435– 1023, byrnesn@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–09– 084: Developmental Biology Research. Date: September 13–14, 2011. Time: 1 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting). Contact Person: John Burch, PhD, Scientific Review Officer, Center for Scientific Review, National Institute of Health, 6701 Rockledge Drive, Room 3213, MSC 7808, Bethesda, MD 20892, 301–408– 9519, burchjb@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; MIT Laser Biomedical Research Center. Date: September 14–16, 2011. Time: 6 p.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: Marriott Wardman Park Washington DC Hotel, 2660 Woodley Road, NW., Washington, DC 20008. Contact: Xiang-Ning Li, MD, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5112, MSC 7854, Bethesda, MD 20892, 301–435– 1744, lixiang@csr.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 47595 Group; Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section. Date: September 15–16, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202. Contact: Boris P Sokolov, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5217A, MSC 7846, Bethesda, MD 20892, 301–408–9115, bsokolov@csr.nih.gov. Name of Committee: Oncology 1–Basic Translational Integrated Review Group; Cancer Etiology Study Section. Date: September 16, 2011. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: InterContinental Chicago Hotel, 505 North Michigan Avenue, Chicago, IL 60611. Contact: Elaine Sierra-Rivera, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6184, MSC 7804, Bethesda, MD 20892, 301–435– 1779, riverase@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: August 1, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–19878 Filed 8–4–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Neurological Disorders and Stroke; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Neurological Disorders and Stroke Special E:\FR\FM\05AUN1.SGM 05AUN1

Agencies

[Federal Register Volume 76, Number 151 (Friday, August 5, 2011)]
[Notices]
[Page 47595]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-19878]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Member Conflict: Chronic Illness and Anxiety.
    Date: August 23, 2011.
    Time: 2 p.m. to 4 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Monica Basco, PhD, Scientific Review Officer, 
RPHB IRG, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3220, MSC 7808, Bethesda, MD 
20892, 301-496-7010, bascoma@mail.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Biology and Diseases of the Posterior Eye.
    Date: September 13, 2011.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Renaissance, Washington, DC Hotel, 999 Ninth Street, NW., 
Washington, DC 20001-4427.
    Contact Person: Noni Byrnes, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5130, MSC 7840, Bethesda, MD 20892, (301)-435-
1023, byrnesn@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-09-084: Developmental Biology Research.
    Date: September 13-14, 2011.
    Time: 1 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892. (Virtual Meeting).
    Contact Person: John Burch, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institute of Health, 6701 
Rockledge Drive, Room 3213, MSC 7808, Bethesda, MD 20892, 301-408-
9519, burchjb@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; MIT Laser Biomedical Research Center.
    Date: September 14-16, 2011.
    Time: 6 p.m. to 12 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Wardman Park Washington DC Hotel, 2660 Woodley 
Road, NW., Washington, DC 20008.
    Contact: Xiang-Ning Li, MD, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 5112, MSC 7854, Bethesda, MD 20892, 301-435-
1744, lixiang@csr.nih.gov.

    Name of Committee: Brain Disorders and Clinical Neuroscience 
Integrated Review Group; Neural Basis of Psychopathology, Addictions 
and Sleep Disorders Study Section.
    Date: September 15-16, 2011.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202.
    Contact: Boris P Sokolov, PhD, Scientific Review Officer, Center 
for Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 5217A, MSC 7846, Bethesda, MD 20892, 301-408-9115, 
bsokolov@csr.nih.gov.

    Name of Committee: Oncology 1-Basic Translational Integrated 
Review Group; Cancer Etiology Study Section.
    Date: September 16, 2011.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: InterContinental Chicago Hotel, 505 North Michigan 
Avenue, Chicago, IL 60611.
    Contact: Elaine Sierra-Rivera, PhD, Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6184, MSC 7804, Bethesda, MD 20892, 301-435-
1779, riverase@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: August 1, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-19878 Filed 8-4-11; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.